Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 98.50
+2.50 (2.60%)
May 8, 2026, 9:41 AM CST
Acer Medical Market Cap
Acer Medical has a market cap or net worth of 1.5 billion as of May 8, 2026. Its market cap has decreased by -27.04% in one year.
Market Cap
1.50B
Enterprise Value
1.32B
Revenue
60.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
98.50
Market Cap Chart
Since October 27, 2021, Acer Medical's market cap has increased from 720.00M to 1.50B, an increase of 108.30%. That is a compound annual growth rate of 17.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.50B | -0.51% |
| Dec 31, 2025 | 1.51B | -30.28% |
| Dec 30, 2024 | 2.16B | -23.66% |
| Dec 29, 2023 | 2.83B | 154.79% |
| Dec 30, 2022 | 1.11B | -1.98% |
| Dec 21, 2021 | 1.13B | 57.50% |
| Oct 27, 2021 | 720.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.72B |
| Caliway Biopharmaceuticals | 161.86B |
| Lotus Pharmaceutical | 62.15B |
| Heron Neutron Medical | 54.11B |
| GeneFerm Biotechnology | 1.56B |
| Cowealth Medical Holding | 1.55B |
| InnoPharmax | 1.54B |
| Advagene Biopharma | 1.51B |